Why losing the wrong kind of fat can trigger diabetes

Diabetes is usually associated with "too much fat" — particularly the fat that accumulates around the abdomen and is thought to drive insulin resistance. But new research suggests the story is considerably more complicated: in some cases, the disease may stem not from excess fat, but from the loss of the healthy fat tissue the body actually needs.

Researchers examined how fat cells — adipocytes — behave under certain conditions of stress. Under normal circumstances, these cells act as a kind of buffer, safely absorbing and storing excess lipids circulating in the bloodstream. But when the cells become damaged, they can lose this storage capacity.

The team observed that damaged fat cells first enter an inflammatory state. This inflammation disrupts the cells' normal function and, over time, causes them to physically shrink and eventually disappear. This process points to something more serious than simple tissue shrinkage — it represents the complete loss of a healthy fat reservoir.

Once that loss occurs, the body no longer has enough "safe space" to store excess lipids. As a result, these lipids begin accumulating in organs not designed for storage, such as muscle, the liver and the pancreas. Scientists believe this misplaced fat is one of the key mechanisms that triggers insulin resistance.

The finding significantly broadens the conventional understanding of how diabetes develops. For a long time, "too much fat" has been cited as the disease's primary driver — but this new research suggests the problem can sometimes be the opposite: an insufficiency of healthy fat tissue. That means the same disease can emerge through two very different biological pathways.

Researchers stress that this distinction matters clinically. If a patient's diabetes stems from a loss of fat tissue rather than an excess of it, standard weight-loss-focused treatments may not have the expected effect. In such cases, a different approach — one aimed at preserving existing healthy fat tissue or supporting the formation of new fat cells — may be needed instead.

Scientists say this mechanism could help explain cases of diabetes seen in some lean but metabolically unhealthy individuals. Because these patients often don't appear overweight, they can be overlooked by standard risk assessments.

The research team says its findings could help point toward new treatment targets. Developing compounds that prevent fat cell inflammation or preserve cells' storage capacity could form the basis of future treatments tailored to this specific type of diabetes.

Experts note that basic science findings like these typically take years to reach clinical practice. Still, the findings strengthen the view that diabetes should be treated not as a single disease, but as a set of conditions that can arise through different biological pathways.

Researchers say the next step is to confirm how far this mechanism holds in humans. If the findings are supported by human studies, it could lead to a meaningful shift in how doctors classify and treat diabetes patients.